Systematic review of N-acetylcysteine in the treatment of addictions

The chemistry and biological activities of N-acetylcysteine

(2013) Yuval Samuni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders

(2013) Ines Peraile et al.   PSYCHOPHARMACOLOGY

The promise of N-acetylcysteine in neuropsychiatry

(2013) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

A Double-Blind Randomized Controlled Trial ofN-Acetylcysteine in Cannabis-Dependent Adolescents

(2012) Kevin M. Gray et al.   AMERICAN JOURNAL OF PSYCHIATRY

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance and therapeutic implications

(2012) S Moylan et al.   MOLECULAR PSYCHIATRY

N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study

(2012) Lianne Schmaal et al.   NEUROPSYCHOPHARMACOLOGY

Oxidative Stress Biomarkers in Some Rat Brain Structures and Peripheral Organs Underwent Cocaine

(2012) Lucyna Pomierny-Chamioło et al.   NEUROTOXICITY RESEARCH

Putative neuroprotective agents in neuropsychiatric disorders

(2012) Seetal Dodd et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individuals

(2012) Elson Asevedo et al.   REVIEWS IN THE NEUROSCIENCES

The Effect of N-Acetylcysteine in the Nucleus Accumbens on Neurotransmission and Relapse to Cocaine

(2011) Yonatan M. Kupchik et al.   BIOLOGICAL PSYCHIATRY

Novel pharmacotherapeutic treatments for cocaine addiction

(2011) Daryl Shorter et al.   BMC Medicine

Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice

(2011) M. De Hert et al.   EUROPEAN PSYCHIATRY

Efficacy and safety of antidepressant drug treatment in children and adolescents

(2011) A Henry et al.   MOLECULAR PSYCHIATRY

Glutamatergic medications for the treatment of drug and behavioral addictions

(2011) M. Foster Olive et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Efficacy of N-Acetylcysteine in the Treatment of Nicotine Dependence: A Double-Blind Placebo-Controlled Pilot Study

(2011) Lianne Schmaal et al.   EUROPEAN ADDICTION RESEARCH

A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence

(2010) Jon E. Grant et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Prodrug Approach for Increasing Cellular Glutathione Levels

(2010) Ivana Cacciatore et al.   MOLECULES

Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trial

(2009) Michelle Bernardo et al.   ACTA NEUROPSYCHIATRICA

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

The Role of Cystine-Glutamate Exchange in Nicotine Dependence in Rats and Humans

(2008) Lori A. Knackstedt et al.   BIOLOGICAL PSYCHIATRY

Glutathione: a novel treatment target in psychiatry

(2008) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

N-Acetylcysteine Reduces Extinction Responding and Induces Enduring Reductions in Cue- and Heroin-Induced Drug-Seeking

(2007) Wenhua Zhou et al.   BIOLOGICAL PSYCHIATRY